News
With US nod for hypertension, Astra Zeneca's Baxfendy takes first step towards $5 B sales goal
1+ hour, 38+ min ago (16+ words) First Word Pharma...
Symbols: lse:azn,nasdaq:azn,btc-usd
Regeneron's LAG-3 inhibitor combo falls short in late-stage melanoma study
14+ hour, 3+ min ago (14+ words) First Word Pharma...
Symbols: tsx:mdna
CDER, CBER leadership purged in wake of Makary's exit
14+ hour, 43+ min ago (11+ words) First Word Pharma...
Symbols: nasdaq:btm
Enhertu adds two more breast cancer indications to its US label
2+ day, 11+ hour ago (13+ words) First Word Pharma...
Symbols: nasdaq:azn,btc-usd,nyse:azn
FDA clears Roche's Tecentriq, paired with ct DNA test, for bladder cancer
2+ day, 13+ hour ago (13+ words) First Word Pharma...
Symbols: nyse:jnj
Amid FDA leadership reset, CDER acting director now also set to exit: report
2+ day, 16+ hour ago (15+ words) First Word Pharma...
Symbols: uq1-F0
Akeso spotlights AML data for anti-CD47 m Ab ahead of EHA
2+ day, 17+ hour ago (13+ words) First Word Pharma...
Symbols: nasdaq:alxo,nasdaq:csbr
How to treat IBD patients during the pandemic
3+ day, 4+ hour ago (10+ words) First Word Pharma...
Symbols: nasdaq:pali
Eisai says Leqembi on track to top $900 M in fiscal 2026
2+ day, 22+ hour ago (13+ words) First Word Pharma...
Symbols: nasdaq:eqix
CREATE pulls in $122 M for cancer, autoimmune in vivo cell therapies
3+ day, 15+ hour ago (13+ words) First Word Pharma...
Symbols: nasdaq:oncy